Concepedia

Marsha E. Stockton

ME

Statistics

Publications

9

Citations

533

H-Index

9

Active since

1990

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

University of Indianapolis

Marsha E. Stockton is an author at Eli Lilly (United States) specializing in neuropharmacology, neuroscience, and pharmacology.

Publications per year

1990–1996

9

Publications

9

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal

Kurt Rasmussen, Ray W. Fuller, Marsha E. Stockton et al. · European Journal of Pharmacology · 1991 · 147 citations

, , +17

Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine Neurons

Marsha E. Stockton, Kurt Rasmussen · Neuropsychopharmacology · 1996 · 123 citations

, , +12

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons

Kurt Rasmussen, Marsha E. Stockton, Janet F. Czachura · European Journal of Pharmacology · 1991 · 58 citations

, , +14

Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

K. Rasmussen, Janet F. Czachura, Marsha E. Stockton et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 56 citations

, , +17

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity

Kurt Rasmussen, Marsha E. Stockton, Janet F. Czachura et al. · European Journal of Pharmacology · 1991 · 53 citations

, , +14

1–5 of 9